[Randomized double-blind therapeutic trial of Statiflor and placebo].
D000117:Acetylglucosamine / Q000008:administration & dosage / Q000627:therapeutic use*; D000284:Administration, Oral; D002480:Cellulase / Q000008:administration & dosage / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003109:Colonic Diseases, Functional / Q000188:drug therapy*; D004311:Double-Blind Method; D004338:Drug Combinations; D004341:Drug Evaluation; D004926:Escherichia coli; D005765:Gastrointestinal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D005944:Glucosamine / Q000031:analogs & derivatives*; D006801:Humans; D009761:Nystatin / Q000008:administration & dosage / Q000627:therapeutic use*; D010919:Placebos; D014815:Vitamins / Q000008:administration & dosage / Q000627:therapeutic use*
D004338:Drug Combinations; D005765:Gastrointestinal Agents; D010919:Placebos; D014815:Vitamins; D009761:Nystatin; C020503:statiflor; D002480:Cellulase; D005944:Glucosamine; D000117:Acetylglucosamine
Essai thérapeutique en double aveugle randomisé Statiflor contre placebo.